Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

2.03
+0.04002.01%
Post-market: 2.030.00000.00%19:30 EDT
Volume:950.42K
Turnover:1.93M
Market Cap:241.74M
PE:-1.45
High:2.06
Open:1.99
Low:1.98
Close:1.99
52wk High:5.55
52wk Low:1.03
Shares:119.08M
Float Shares:108.42M
Volume Ratio:0.68
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:21.13
PE(LYR):-1.58

Loading ...

Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 01, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 01, 2022

Major Issues Report

8-K - Current report
Nov 01, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 07, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Major Issues Report

8-K - Current report
Jul 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 13, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2022

Major Issues Report

8-K - Current report